Last updated: December 18, 2024
Sponsor: Lady Davis Institute
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Written informed consent with infographic
Compensation
Clinical Study ID
NCT06588101
2024-4023
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Has family member admitted to an intensive care unit.
Expected hospital stay > 48 hours
Able to participate in English or French
Exclusion
Exclusion Criteria:
Has another family member participating in the trial
Repeat admissions within the study period
Study Design
Total Participants: 160
Treatment Group(s): 2
Primary Treatment: Written informed consent with infographic
Phase:
Study Start date:
May 01, 2024
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Jewish General Hospital
Montreal, Quebec
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.